Repo, Baby Boy .

HRN: 28-68-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2026
AMPICILLIN 250MG (VIAL)
03/09/2026
03/16/2026
IV
135MG
Q12
NEONATAL SEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: